CN1250097C - Health-care and nutrient oil with functions of fatigue-resistance and antilipenic - Google Patents
Health-care and nutrient oil with functions of fatigue-resistance and antilipenic Download PDFInfo
- Publication number
- CN1250097C CN1250097C CN 200310110776 CN200310110776A CN1250097C CN 1250097 C CN1250097 C CN 1250097C CN 200310110776 CN200310110776 CN 200310110776 CN 200310110776 A CN200310110776 A CN 200310110776A CN 1250097 C CN1250097 C CN 1250097C
- Authority
- CN
- China
- Prior art keywords
- oil
- vitamin
- present
- health care
- maize germ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000015097 nutrients Nutrition 0.000 title 1
- 240000008042 Zea mays Species 0.000 claims abstract description 19
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 19
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 16
- 235000009973 maize Nutrition 0.000 claims abstract description 16
- 230000036541 health Effects 0.000 claims abstract description 9
- 210000004369 blood Anatomy 0.000 claims abstract description 6
- 239000008280 blood Substances 0.000 claims abstract description 6
- 150000002632 lipids Chemical class 0.000 claims abstract description 6
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 claims description 24
- 239000003921 oil Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 22
- 229960002666 1-octacosanol Drugs 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 5
- 230000002929 anti-fatigue Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000050 nutritive effect Effects 0.000 claims description 4
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 239000008165 rice bran oil Substances 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 39
- 229930003427 Vitamin E Natural products 0.000 abstract description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 18
- 235000019165 vitamin E Nutrition 0.000 abstract description 18
- 239000011709 vitamin E Substances 0.000 abstract description 18
- 229940046009 vitamin E Drugs 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- ZYURHZPYMFLWSH-UHFFFAOYSA-N octacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC ZYURHZPYMFLWSH-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000020795 whole food diet Nutrition 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- -1 tocopherol hydroxyl radical free radical Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940083040 vitamin E pill Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to health care nutrition oil for resisting fatigue and reducing blood lipid, which relates to health care nutrition oil prepared by extracting natural food. In view of the prior art, the present invention provides health care nutrition oil prepared by extracting natural food and has integrated effect of resisting fatigue and reducing blood lipid by individual component application. The present invention has the technical scheme that the health care nutrition oil is prepared from the following components: 0.125 to 2 mg of twenty-eight baked alcohol, 25 to 100 IU of vitamin E and 398 to 474.875 mg of maize germ oil.
Description
One, technical field
The present invention relates to a kind of the extraction and prepare health nutritive oil with antifatigue, reducing blood lipid from wholefood.
Two, background technology
The developing history of China's health food is very long, and the viewpoint of " integration of drinking and medicinal herbs " and " Diet cures more than the doctors " is arranged very early.
Modern medicine proves, long-term edible corn embryo oil has tangible clinical effectiveness to improving angiocardiopathy, Japan shows that to the result of study of rice bran oil, sunflower oil and maize germ oil the three is respectively 18%, 13% and 16% to the reduced rate of human serum cholesterol.The corn refined oil was once sold in the pharmacy as health care oil for a long time.Except that rising aspect angiocardiopathy the prevention effect, maize germ oil also embodies certain function in the control of keratitis, yctalopia.This is the result than physiologically active ingredient comprehensive functions such as the vitamin E of rational aliphatic acid composition, relative high-load and phytosterols.
The physiologic function of vitamin E is the scavenger as free radical, prevents the damage of the protein component that is rich in sulfydryl and the cytoskeleton and the nucleic acid of polyunsaturated fatty acid, film in free radical or the oxidant cell membrane.Many cell systems, the transmission of mitochondria electronics and be exposed to various environmental factors and all can normally generate responding property ground oxygen class and other free radical; vitamin E can directly be protected cell membrane because of it is fat-soluble in free radical detoxification system of defense, the tocopherol hydroxyl radical free radical that generates after reacting with free radical can be reduced to tocopherol again by vitamin C, glutathione and ubiquinone again.
N-octacosanol is a kind of naturally occurring monobasic higher alcohol, find that from the nineteen thirty-seven foreign scholar it has carried out systematic research to medical function to 1949 year doctor Cureton of human reproductive system's disease to it, the effect of n-octacosanol is just gradually well known, it also has special physiologically active as alcohols except the physicochemical property with general alcohol.N-octacosanol has following effect to human body: (1) promotes endurance, energy; (2) improve being quick on the draw property; (3) improve stress ability; (4) promote hormonal action, alleviate myalgia.
Along with going deep into of social economy's construction, improving constantly of living standards of the people, the quickening of live and work rhythm, the popularizing of amusement and leisure activity and physical training, people are managing to seek a kind of can refreshing and physical fatigue always, prolong the material of work and exercise tolerance.
Vitamin E pill on sale on the market is single composition.At Japan Patent JP60149367, " a kind of capsule that contains the viscose glue extract " disclosed, be to contain vitamin E.At BP EP1161884, " a kind of supply of the living power food based on Nadide, the pure and mild vitamin E of octacosane " disclosed, be oral liquid through emulsification.All there is not maize germ oil, its function singleness.
Three, summary of the invention
The purpose of this invention is to provide and a kind ofly extract preparation, have the health nutritive oil of antifatigue, reducing blood lipid resultant effect through wholefood.
The technical scheme that purpose of the present invention adopted is, and is formulated by following composition, n-octacosanol 0.125-2mg, vitamin E 25-100IU, maize germ oil 398-474.875mg.
The n-octacosanol that the present invention adopted be from rice bran oil processing and accessory substance, use extraction and solvent crystallization and the higher alcohol that makes.People specialize in the toxicity of n-octacosanol, confirm white mouse half lethal dose LD by acute toxicity test
50=18000mg/kg (white mouse is oral), security is than salt height (salt LD
50=3000mg/kg).Zhejiang Medical university Yan Jixiang professor's demonstration has also confirmed this point.The quality standard of the n-octacosanol that the present invention uses is:
Molecular formula: CH
3(CH
2)
26CH
2OH
Relative molecular mass: 410
Outward appearance: white powder
Moisture and volatile matter content≤0.5%
Ash content :≤0.4%
Content: 〉=12-90% (GC detection) (complete in specifications)
Total pure content: 〉=98%
Content of beary metal: plumbous (Pb)≤10mg/kg
Arsenic (As)≤1.5%mg/kg
Microorganism detection: total number of bacteria≤3000cfu/g
Escherichia coli: must not detect
Fusing point 80-83 ℃
Sieve mesh is analyzed 80 orders
Vitamin E of the present invention is to extract from soybean with molecularly distilled to form, and vitamin E and blood plasma cholesterol level have stronger correlation.People such as Qureshi (1992) have studied the influence of each isomers of vitamin E to the chicken of trouble hypercholesterolemia, find that each isomers of vitamin E all has the function that reduces cholesterol.
Vitamin E at first is to be applied to medicine and food, and its security just becomes the problem that people extremely pay close attention to.Generally speaking, human body can tolerate megavitamin E well, and the adult can tolerate 200-800mg tocopherol equivalent and illeffects do not occur every day safely.At present, in the U.S., select every day the best intake in meals of 100-400IU as vitamin E, the recommendation of this standard is based on all that to avoid taking place chronic disease dangerous and improve that wholesome results of study such as body immune function advocate.Its quality of vitamin E that the present invention uses meets standard.
Maize germ oil of the present invention is the edible oil and fat through refining that extract from maize germ.Aliphatic acid in the maize germ oil mainly is linoleic acid (32%-62%), oleic acid (19%-50%) and palmitic acid (8%-19%).Linolenic content is about 0.3%-2.7%, scarcely surpasses 1%, and leukotrienes level that the maize germ oil pole is low and shortage laurate make it show hydrolysis or oxidation resistant highly stability at lay up period.Modern medicine proves that long-term edible corn embryo oil has tangible clinical effectiveness to improving angiocardiopathy.The maize germ oil quality that the present invention uses meets national refining of edible standard.
Preparing process of the present invention stirs by weight n-octacosanol, vitamin E, maize germ oil being put into pincers pots, through the injection soft capsule moulding of packing into, again pelleting, typing, drying, choose operation such as ball, be packaged into bottle at last.
Edible the present invention, one day edible 2 times, early, each is edible once in dinner, and each 2, every 500mg.
It is precise and appropriate that the present invention has compatibility, brings out the best in each other, and preparation is simple, taking convenience, the nutritional oil that is particularly suitable for taking for a long time.
Five, the specific embodiment
Further specify the present invention below in conjunction with three embodiment.
Embodiment 1 n-octacosanol 0.5mg, vitamin E 40IU, maize germ oil 410mg.
Embodiment 2 n-octacosanol 1mg, vitamin E 60IU, maize germ oil 430mg.
Embodiment 3 n-octacosanol 1.8mg, vitamin E 85IU, maize germ oil 470mg.
Claims (1)
1, the health nutritive oil of a kind of antifatigue, reducing blood lipid, it is characterized in that by following composition formulated, the n-octacosanol 0.125-2mg that from rice bran oil, extracts with extraction and solvent crystallization, the vitamin E2 5-100IU, the maize germ oil 398-474.875mg that refining forms from maize germ that from soybean, extract with molecularly distilled.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310110776 CN1250097C (en) | 2003-10-23 | 2003-10-23 | Health-care and nutrient oil with functions of fatigue-resistance and antilipenic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310110776 CN1250097C (en) | 2003-10-23 | 2003-10-23 | Health-care and nutrient oil with functions of fatigue-resistance and antilipenic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1537442A CN1537442A (en) | 2004-10-20 |
| CN1250097C true CN1250097C (en) | 2006-04-12 |
Family
ID=34335720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200310110776 Expired - Fee Related CN1250097C (en) | 2003-10-23 | 2003-10-23 | Health-care and nutrient oil with functions of fatigue-resistance and antilipenic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1250097C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112889933A (en) * | 2021-03-09 | 2021-06-04 | 汪智强 | Health-care nutrient oil with functions of resisting fatigue and reducing blood fat |
-
2003
- 2003-10-23 CN CN 200310110776 patent/CN1250097C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1537442A (en) | 2004-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhou et al. | Silkworm pupae: a functional food with health benefits for humans | |
| CN105050594B (en) | For generating the composition and method that increase with lasting ketosis | |
| Rastogi | Provisioning services from ants: food and pharmaceuticals | |
| WO2009009040A2 (en) | Fatty acid compositions and methods of use | |
| El-Sabrout et al. | Current applications and trends in rabbit nutraceuticals | |
| Shrestha et al. | Effects of monosodium glutamate on liver tissue of Wistar albino rats-A histological and biochemical study | |
| TWI440458B (en) | Containing sesamin and arachidonic acid | |
| CN101077130A (en) | Immune-strengthened type feed formula technology for meat chicken | |
| CN1250097C (en) | Health-care and nutrient oil with functions of fatigue-resistance and antilipenic | |
| CN1301665C (en) | Blood fat-regulating liver-protecting health food | |
| CN1255167C (en) | Anti-oxidation health care nutrient oil | |
| Shrivastava et al. | Insect for nutraceutical: an unexplored wealth of India | |
| Mustafa et al. | The Effect of ChannastriataExtract on Total Amino Acid, Arginine, and Leucine Consentration in Serum of Streptozotocin Induced Diabetic Rat | |
| Kurchaeva et al. | Use of inulin and topinambur food fibers in meat-based system with addition of rabbit meat | |
| CN1864708A (en) | Blood sugar-decreasing health food | |
| WO2007116980A1 (en) | Suppressor of increase in blood glucose level | |
| Ahmad et al. | Efek Pemberian Minyak Buah Zaitun (Olea Europaea L) Dosis Rendah Terhadap Kadar Malondialdehid (MDA) Tikus Putih (Rattus Norvegicus) Obesitas | |
| Dwivedi et al. | Nutrient Requirements in Health and Disease | |
| CN1689425A (en) | Health caring soft capsule of corn oil | |
| Yun et al. | Effect of the supplementation of Coconopsis lanceolata extract on lipid metabolism amelioration in type 2 diabetes mouse model induced by high fat diet | |
| JP2005295840A (en) | Healthy devil's tongue | |
| CN1245959C (en) | Healthy products for regulating blood fat and removing heat from throat | |
| Salhab | A Minireview on Mushroom: Emphasis on the Wild Mushroom of Jordan (Review Articles) | |
| WO2023120373A1 (en) | Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from docosahexaenoic acid | |
| WO2023120368A1 (en) | Oral composition, and method for suppressing bitterness derived from ergothioneine or salt thereof and odor derived from eicosapentaenoic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060412 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |